Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, August 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Improve Gene Expression Results with Bio-Rad’s New Rapid Cell Lysis RT-qPCR Kits
Monday, August 18, 2014
The kits allow researchers to obtain reverse transcription quantitative PCR (RT-qPCR) data directly from cultured cells without the need for a separate RNA purification step.

Merck Millipore Introduces Magna™ Nuclear RIP Kits
Tuesday, August 05, 2014
Facilitates isolation and analysis of RNA molecules associated with chromatin.

Analytik Jena Launches New Generation of Thermal Cyclers
Tuesday, August 05, 2014
TAdvanced from Analytik Jena gives excellent heating and cooling rates.

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology
Thursday, July 24, 2014
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

Bio-Rad Introduces Bio-Plex Pro™ RBM Human Metabolic and Hormone Assays
Thursday, July 17, 2014
Developed in partnership with Myriad RBM, Inc., these multiplex immunoassays permit robust and simultaneous quantification of a highly relevant set of protein biomarkers for the study of diabetes, obesity, and metabolic syndrome, as well as related conditions such as cardiovascular disease and inflammation.

ACD’s RNAscope® In Situ Hybridization Technology Gains Significant Traction
Wednesday, July 16, 2014
Highly sensitive and easy-to-use technology validated in over 100 papers in three years.

Olink Bioscience Introduces a 92-protein Biomarker Panel
Wednesday, July 02, 2014
Proseek® Multiplex Inflammation I 96x96 for inflammatory diseases.

Tecan Unveils Fluent™ Laboratory Automation Solutions
Tuesday, June 24, 2014
Tecan has introduced the Fluent™ laboratory automation solution, the latest addition to its world-class laboratory automation portfolio.

New Molecular Biology Tools Drive Efficiency across a Range of Applications
Wednesday, June 11, 2014
New convenience features and rapid protocols leave more time for analysis and discovery.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 707
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv